C. Müller, P. L. Maclot, T. Sas, . Co, K. Chau et al.,

P. Cimon, E. Eby, L. Merckle, M. Batsh, O. Blanger et al., Imaging engineer: Bozec E. Laboratory Engineer: Nuée-Capiaumont J, and Technicians

S. Bouali, C. Hertz, M. Giansily, L. Poinsignon, N. Robin et al., Quality engineer: Lepage X. Registered Nurses

M. T. Fleurot, R. Alvarez-vasquez, M. Amiot, M. Angotti, E. Babel et al.,

M. Bannay, A. Basselin, P. Benoit, P. Bercand, J. Bouazzi et al.,

F. Boyer, C. Champagne, S. A. Chenna, J. Clochey, D. Czolnowski et al.,

G. , K. C. Laurière, E. Legay, M. Mansuy, A. Millet-muresan et al., Pathogenesis of essential hypertension: historical paradigms and modern insights, J Hypertens, vol.26, issue.3, pp.381-91, 2008.

M. Kanbay, T. Jensen, Y. Solak, M. Le, C. Roncal-jimenez et al., Uric acid in metabolic syndrome: From an innocent bystander to a central player, Eur J Intern Med, vol.29, pp.3-8, 2016.

T. Jensen, K. Niwa, I. Hisatome, M. Kanbay, A. Andres-hernando et al., Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver, Sci Rep, vol.8, issue.1, p.11735, 2018.

A. Kanbay, H. Inonu, Y. Solak, A. Erden, E. Uslu et al., Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome

, Eur J Intern Med, vol.25, issue.5, pp.471-477, 2014.

T. Nakagawa, K. R. Tuttle, R. A. Short, and R. J. Johnson, Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome, Nat Clin Pract Nephrol, vol.1, issue.2, pp.80-86, 2005.

A. Yerlikaya, T. Dagel, C. King, M. Kuwabara, M. A. Lanaspa et al., Dietary and commercialized fructose: Sweet or sour?, Int Urol Nephrol, vol.49, issue.9, pp.1611-1631, 2017.

O. C. Eren, A. Ortiz, B. Afsar, A. Covic, M. Kuwabara et al., Multilayered Interplay Between Fructose and Salt in Development of Hypertension, Hypertension, vol.73, issue.2, pp.265-72, 2019.

M. Mazzali, J. Hughes, Y. Kim, J. A. Jefferson, D. Kang et al., Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism, Hypertension, vol.38, issue.5, pp.1101-1107, 2001.

M. Mazzali, M. Kanbay, M. S. Segal, M. Shafiu, D. Jalal et al., Uric acid and hypertension: cause or effect?, Curr Rheumatol Rep, vol.12, issue.2, pp.108-125, 2010.

D. H. Kang, T. Nakagawa, L. Feng, S. Watanabe, L. Han et al., A role for uric acid in the progression of renal disease, J Am Soc Nephrol, vol.13, issue.12, pp.2888-97, 2002.

M. Kanbay, M. Segal, B. Afsar, D. H. Kang, B. Rodriguez-iturbe et al., The role of uric acid in the pathogenesis of human cardiovascular disease, Heart, vol.99, issue.11, pp.759-66, 2013.

J. P. Ferreira, N. Girerd, E. Bozec, L. Merckle, A. Pizard et al., Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France, Int J Epidemiol, vol.47, issue.2, p.395, 2018.

N. Sauvageot, A. Alkerwi, A. Albert, and M. Guillaume, Use of food frequency questionnaire to assess relationships between dietary habits and cardiovascular risk factors in NESCAV study: validation with biomarkers, Nutr J, vol.12, issue.1, p.143, 2013.

G. Mancia, R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti et al., , 2013.

, ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J, vol.34, issue.28, pp.2159-219, 2013.

, American Diabetes A. Diagnosis and classification of diabetes mellitus, Diabetes Care, vol.33, issue.1, pp.62-71, 2010.

S. F. Nagueh, C. P. Appleton, T. C. Gillebert, P. N. Marino, J. K. Oh et al., Recommendations for the evaluation of left ventricular diastolic function by echocardiography, Eur J Echocardiogr, vol.10, issue.2, pp.165-93, 2009.

T. H. Marwick, T. C. Gillebert, G. Aurigemma, J. Chirinos, G. Derumeaux et al., Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)dagger, Eur Heart J Cardiovasc Imaging, vol.16, issue.6, pp.577-605, 2015.

, Adjustment 1: age, gender, current smoker, BMI, total cholesterol (+ fasting blood glucose, gout treatment and antihypertensive treatment for Uric acid at V4)

*. Adjustment, Adjustment 1 + SBP. Abbreviations: SBP: Systolic blood pressure, DBP: Diastolic blood pressure, eGFR: estimated glomerular filtration rate, BMI: Body mass index. PWV: pulse wave velocity, vol.2